Assessment of patient satisfaction with dupilumab for chronic rhinosinusitis with nasal polyps
- PMID: 39412479
- DOI: 10.1111/all.16355
Assessment of patient satisfaction with dupilumab for chronic rhinosinusitis with nasal polyps
References
REFERENCES
-
- De Corso E, Pasquini E, Trimarchi M, et al. Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric observational phase IV real‐life study (DUPIREAL). Allergy. 2023;78(10):2669‐2683.
-
- Bharmal M, Payne K, Atkinson MJ, Desrosiers MP, Morisky DE, Gemmen E. Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM‐9) among patients on antihypertensive medications. Health Qual Life Outcomes. 2009;27(7):36.
-
- van der Lans RJL, Otten JJ, Adriaensen GFJPM, et al. Two‐year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6 months. Allergy. 2023;78(10):2684‐2697.
-
- van den Reek JM, van Lüumig PP, Otero ME, et al. Satisfaction of treatment with biologics is high in psoriasis: results from the Bio‐CAPTURE network. Br J Dermatol. 2014;170(5):1158‐1165.
-
- Aggarwal AN, Kumari R, Grover S. Patient satisfaction with inhaled medication for asthma. Respir Care. 2018;63(7):859‐864.
Publication types
LinkOut - more resources
Full Text Sources
